The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8610979 8747131 I 8610979-X 20110606 20120420 PER WAES 1106USA00698 MERCK + CO., INC. 53 YR F N 20120419 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8610979 1020622752 PS SINGULAIR 1 ORAL 5 MG/DAILY/PO U D 20830

Indications of drugs used

Event ID DRUG SEQ INDI PT
8610979 1020622752 HYPERSENSITIVITY

Outcome of event

Event ID OUTC COD
8610979 OT

Reactions reported

Event ID PT
8610979 CONVULSION
8610979 TREMOR
8610979 ABNORMAL BEHAVIOUR
8610979 HALLUCINATION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
8610979 CSM

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
8610979 1020622752 20100101